Skip to main content
Clinical Trials/KCT0006248
KCT0006248
Completed
未知

Comparison of bispectral index(BIS) change and clinical signs of awakening during sugammadex reversal of neuromuscular block according to the depth of propofol-remifentanil anesthesia

Samsung Medical Center0 sites66 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Samsung Medical Center
Enrollment
66
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 28, 2022
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Patents who have American society of anesthesiologist physical status I to III
  • 2\) Patients who are planned to undergo elective major abdominal surgery using propofol\-remifentanil anesthesia taking one hour or more.

Exclusion Criteria

  • 1\) Pediatric patient at or under 18\.
  • 2\) Body Mass Index \> 35 kg / m 2 or \<18\.5 kg / m 2
  • 3\) Severe liver disease
  • 4\) Severe kidney disease (GRF \<30 or under hemodialysis)
  • 5\) Neuromuscular disease or mental illness
  • 6\) Those diagnosed with metabolic diseases
  • 7\) Drug addiction or alcohol addiction
  • 8\) Emergency surgery
  • 9\) Pregnant women or nursing women
  • 10\) People who have contraindications to muscle relaxants and sugammadex

Outcomes

Primary Outcomes

Not specified

Similar Trials